HCA Healthcare, Inc.

  • Market Cap: Large Cap
  • Industry: Hospital
  • ISIN: US40412C1018
USD
487.66
0.89 (0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About HCA Healthcare, Inc. stock-summary
stock-summary
HCA Healthcare, Inc.
Hospital
HCA Healthcare, Inc., formerly HCA Holdings, Inc., is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia. As of December 31, 2016, the American Group included 80 hospitals, which were located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. As of December 31, 2016, the Company operated six hospitals in England. The Company owns, manages or operates hospitals, freestanding surgery centers and freestanding emergency care facilities, walk-in clinics, diagnostic and imaging centers, among others.
Company Coordinates stock-summary
Company Details
1 Park Plz , NASHVILLE TN : 37203-6527
stock-summary
Tel: 1 615 3449551
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 180 Schemes (23.53%)

Foreign Institutions

Held by 483 Foreign Institutions (17.41%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Thomas Frist
Chairman of the Board
Mr. Samuel Hazen
Chief Executive Officer, Director
Mr. William Frist
Director
Ms. meg Crofton
Independent Director
Mr. Robert Dennis
Independent Director
Ms. Nancy-Ann DeParle
Independent Director
Mr. Charles Holliday
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
18,605 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,891 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 97,833 Million (Large Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

76.73%

stock-summary
Debt Equity

-9.89

stock-summary
Return on Equity

-156.67%

stock-summary
Price to Book

-22.27